The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of capecitabine and temozolomide (CAPTEM) in patients with gastrointestinal neuroendocrine tumors (GI-NETs).
 
Sherwin Kelekar
No Relationships to Disclose
 
Sadiq Rehmani
No Relationships to Disclose
 
Alexander Bray
Stock and Other Ownership Interests - Procter & Gamble
 
Vaibhav Sahai
Consulting or Advisory Role - AstraZeneca; Autem Medical; Civala; Civala; Delcath Systems; Elevar Therapeutics; Histosonics; Incyte; Ipsen; Jazz Pharmaceuticals; Lynx Group; Revolution Medicines; SERVIER; Tallac Therapeutics; TransThera Biosciences
Research Funding - Actuate Therapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Elicio Therapeutics (Inst); Esanik (Inst); Exelixis (Inst); FibroGen (Inst); Ipsen (Inst); Jazz Pharmaceuticals (Inst); MedImmune (Inst); Pancreatic Cancer Action Network (Inst); Rafael Pharmaceuticals (Inst); Relay Therapeutics (Inst); Relay Therapeutics (Inst); Repare Therapeutics (Inst); SERVIER (Inst); Syros Pharmaceuticals (Inst); TransThera Biosciences (Inst)
Other Relationship - Rafael Pharmaceuticals (Inst)